Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tonix Pharmaceuticals Holding (TNXP) Debt to Equity (2023 - 2024)

Historic Debt to Equity for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Q4 2024 value amounting to $0.05.

  • Tonix Pharmaceuticals Holding's Debt to Equity fell 3646.95% to $0.05 in Q4 2024 from the same period last year, while for Dec 2024 it was $0.05, marking a year-over-year decrease of 3646.95%. This contributed to the annual value of $0.05 for FY2024, which is 3646.95% down from last year.
  • Per Tonix Pharmaceuticals Holding's latest filing, its Debt to Equity stood at $0.05 for Q4 2024, which was down 3646.95% from $0.11 recorded in Q3 2024.
  • Tonix Pharmaceuticals Holding's 5-year Debt to Equity high stood at $0.2 for Q2 2024, and its period low was $0.05 during Q4 2024.